• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Compounds of formula I …<CHEM>… in which n = 0 or 1;… in which, when n = 0, R1 is H, an alkyl, a cycloalkyl, a cycloalkylmethyl, an alkenyl or, an alkynyl group a heterocyclic ring or an optionally substituted phenyl rig or when n = 1, R1, is H or an alkyl group;… in which R2 and R3 and H or an alkyl group;… in which A is a group of formula III… -(CH2)x-W-(CH2)y- III… in which W is an oxygen atom or a group of formula -S(O)m-, a group of formula -CR12R13-, a cycloalkylidene group or a cycloalkylene group, x is 0 or an integer from 1 to 5; y is 0 or an integer from 1 to 5.… in which R4 is a carbocyclic ring, a heterocyclic ring, a cyano group, a carbamoyl group, an alkoxylcarbonyl group, an amido group, an acyloxy group, a hydroxy group, a thiol group, or a group of formula -OR20, -SR20, -SOR20 or SO2R20.… in which R5, R6 and R7 and H, halo, trifluoromethyl, hydroxy, an alkyl group, an alkoxy or alkylthio group, phenyl or R5 and R6, together with the carbon atoms to which they are attached, form an optionally substituted second benzene ring;… in which R8 and R9 and H or an alkyl group containing 1 to 3 carbon atoms;… and pharmaceutically acceptable salts thereof have utility in the treatment of depression. Processes for their preparation and compositions containing them are disclosed.
    公开号:SU1209026A3
    申请号:SU833647537
    申请日:1983-09-29
    公开日:1986-01-30
    发明作者:Козлик Антонин；Хейс Веллс Велфред
    申请人:Дзе Бутс Компани Плс (Фирма)；
    IPC主号:
    专利说明:

    have the above Ziache - /, 1st 5
    In the medium of an organic; solvent 5 selected from methanol, ethanol and propan-2-ol, in the presence of borhydride
    The invention relates to organic chemistry, namely to the method of half a century of new derivatives of arylcyclobutylalklaminic compounds, which have antidepressant activity and can be used in medicine,
    The purpose of the invention is the preparation of new derivatives of arylcyclobutylalkyl-amine compoundsJ which can be used in medicine as an anti-D.pressant
    Example 1 Hydrochlorine; N - benzyl-1 - (3 5 4 - d, ichlorophenylcyclobutylI ethylamine,
    1 Acetyl-i (3 9 4-dichlorophenyl) cyclobutane (4s86r) and benzylamine (2.2 ml) are stirred at a temperature of 40-150 C under nitrogen. within 1 h 30 min Methanol (500 ml) was added to the cooled reaction mixture and borog-sodium sulfate (0.8 g) was added over 10 minutes. The mixture is then stirred at ambient temperature for 2 hours and then the volume of the reaction mixture is reduced by half and the mixture is poured into water (300 p.). The aqueous solution is extracted with ether and the ether extract is dried and the ether is removed by evaporation. The residue is distilled (b.p., 182-186 ° C at Oj5 mth Hg) and the distillate is treated with simple hydrogen chloride. ether 5 as a result of which N-6enzyl-1 (3,4-dichlorophenyl) cyclobutyl ethylamine hydrochloride is obtained. (mp 227-228 C),
    EXAMPLE 2 - .37, Using the same procedure as described in example 1., compounds j listed in Tables 1 and 2 are obtained,
    EXAMPLE 38 1-Acetyl- (354-dichlorophenyl) cyclobutane (5.0 g) was added B 2 nd Propoxyethylalanine (Ij9 g) and the mixture was stirred and
    sodium nitride or gtianborohydride sodium at a temperature from ambient temperature to:.: boiling point temperature of the reaction mixture.
    0
    five
    0
    five


    0
    five
     heated to 140-145 ° C in a slowly purged stream of nitrogen, which is used to remove the water formed, heating is continued for 20 hours in the mixture is cooled and a suspension of sodium borohydride (707 mg) in propane-2-ol (60 ml) is added, and then the mixture is H-stirred to a reflux temperature which is maintained for 16 hours. The solvent is removed and the residue is taken up in water (150 ml) and the product is extracted into ether. The extract is washed with water (10 X 75 ml), dried, filtered and the solution of maleic acid (.2513 g) in ether (100 ml) is added to the mixture. The mixture is cooled, the resulting solid recrystallized from technical methylated alcohol. , resulting in a maleate of N- (2-nponoK-ethyl) 1 - (3.4 dichlorophenyl) 1, iclobutyl ethylamine (t, mp, 12-114 C),
    Examples 39-52; Using a procedure similar to that used in Example 38s, the compounds listed in Table 3 and 4 ° were obtained.
    Examples 53-66, The compounds shown in Tables 5 and 6 were obtained using the same procedure as described in either the example or in example 38.
    In the tables indicated:
    -L and J.I (cm, headings of tables) duration (h) and temperature (C), at. which is reacted. between ketone and amine;
    in the column Note:
    (1) - the product was purified by high pressure liquid chromatography. Physical constants were not defined;
    (2) is the boiling point of the free base;
    3
    (3) monochlorohydrate salt;
    (4) - dichlorh and salt;
    (5) -L- form;
    (6) - salt of dimaleate;
    (7) monomelate salt;
    (8) monohydrate;
    (9) - contains 1.45 moles of HC1 per mole;
    (10) - hemihydrate;
    (11) - physical constants were not determined, but the structure of the compound was analyzed using well-known analytical methods;
    (12) - the solvent of the step of the reduction was ethanol;
    (13) - the solvent of the reduction stage was methanol;
    (14) the solvent of the reduction step was a mixture of ethanol and methanol,
    PRI me R 67. Using a procedure similar to that described in Example 38, a hydro-. N- (2-methoxyethyl) -1-D (3,4-dichlorophenyl) 11 11-cyclobutyl -2-methyl-propylamine chloride (mp. 158-16 ° C),
    PRI me R 68. A mixture of 1-acetyl- 1- (3,4-dichlorophenyl) cyclobutane (2.43 g) of glidinamide hydrochloride (2.21 g), powdered potassium hydroxide powder (1.2 g) and cyanoborohydride and sodium (1.5 g) in methanol (20 ml) is stirred at 2 hours, then another 10 days at ambient temperature. The mixture is cooled and a 5N-hydrochloric acid solution is added. The mixture is then alkalinized, extracted with ether, washed with water, dried and evaporated to give an oil, which is dissolved in ether and a solution of maleic acid (1.0 g) in dry ether (100 ml) is added, in resulting in an oil that dissolves in acetone. Ether is then added, whereby a more solid substance is obtained, which is dissolved in water, made basic, and extracted with ether. Hydrogen chloride gas passes through
    09026
    the dried ether extract, C 1 hydrochloride (3,4-dichlorophenyl (cyclobutyl ethylaminoacetamide (mp 240-245 C), 5 Example 69) is obtained. A mixture of 2- (4-methoxyphenoxy) ethylamine (7.0 g ), 1-butyryl-1- (3,4-dichlorophenyl) cyclobutane (10.8 g) and dibutyltin dichloride (0.61 g) in dry toluene (20 ml) are stirred and refluxed for 2 hours, the toluene is removed by evaporation and the mixture is heated to 175-1BO C .erne for 7 hours. The mixture is cooled, dissolved in absolute ethanol (25 ml), then added to a solution of sodium borohydride (5 g) in ethanol (250 ml) and the mixture is heated to reflux temperature. - rovani, to the torus is maintained for 2 hours. The ethanol is evaporated and
    20, the mixture is acidified, alkalinized and extracted with ether. Hydrogen chloride is passed through the dried extracts, resulting in a sticky solid,
    25 which is distributed between ether and 5H. sodium hydroxide solution. A layer of ether washed with 5N. with a solution of hydrochloric acid, alkalinized, extracted with ether and dried. A solution of maleic acid (3g) in dry ether (300 ml) is added, resulting in a yield of (4-methoxyphenoxy) (3,4-dichlorophenyl) cyclobutyl butylamine maleate (mp. 164-1b C).
    Example 70: Mixture of a compound from Example 37 in the form of its free base (3.2 g), 98% solution
    For formic acid (2 ml), 37-AO% aqueous formaldehyde solution (2.8 ml) and water (0.28 ml) are heated to a temperature of 90-95 ° C, which is maintained for 18 hours. After cooling concentrated acid (1 ml) and the reaction mixture is allowed to dry. The residue is triturated with ether to give N-methyl-K- (2-morpholinoethyl) -1 -1- (4-chlorophenyl) cyclobutyl ethylamine hydrate N-methyl-1- (4-chlorophenyl) cyclobutyl ethylamine hydrate (m.p. ).
    five
    ABOUT
    CH,
    chlorphenylthio
    Iklogept- 16,140 1-ethyl
    Table 1
    / O, 1 mm Hg, Art.
    179-180 /
    / 0.1 mm Hg
    (2)
    0.2 mm Hg
    1-, ™ CHNH (CHo)
     I g u
    3 ff
    W li
    Me
    CHNH (CH2) xW (CR2, yH6
    44 2 2 0
    Ome
    Table 2
    Table3
    1 10
    119-120
    (7) (12)
    t
    ctj
    n
    IS
    R y
     "N.
    f
    1L
    -ir 1L
    in ifl
    t
    L
    t
    LO
    about
    h
    about
    ABOUT
    - see what cho
    n in
    D tt) 3 IS
    t;
    lO
    (fl
    H
    U3

     eJ5
    E
    I
    C) 1209026
    sixteen
    权利要求:
    Claims (1)
    [1]
    METHOD FOR PRODUCING GENERAL FORMULATION Arylcyclo-butylalkylamine compounds
    Ay- | - where is a straight or branched C-alkyl or cyclohexylmethyl;
    Ar - a group of formula - (CH2) ~ X '- (CH 2) y where ad - oxygen or sulfur, cyclohexylene or cyclohexylidene group, or a group of formula
    -SK, H 4 where R ^ -C V3 is alkyl, hydroxy, methoxy or benzyl group;
    R 4 is hydrogen or C t _ 3 is alkyl;
    x is an integer from 0 to 4;
    y is an integer from 0 to 4, provided that when ω is oxygen or sulfur, x and y are not equal to 0;
    R 2 -hydroxy-, C ( _ 4- alkoxy-, φβ. Hydroxy or cyano, phenyl, phenyl substituted with one or two halogen atoms, halogenophenylthio group, thienyl, pyridyl, furyl, tetrahydrofuryl, morpholino-, thiomorpholino-, piperidino or a pyrrolidino group, imidazolyl, triazolyl or cycloheptenyl; '.
    Ar - 2-fluorophenyl, a group of the formula
    And where R 5 is hydrogen or halogen, or trifluoromethyl;
    R 6 is hydrogen or halogen, phenyl or methylthio group or R 5 and R 6 together with the carbon atoms to which they are attached form an additional benzene ring, or an Ag group of the formula or their pharmaceutically acceptable salts, characterized in that the compound of the general formula
    COTR tl where Ar and R ( have the indicated meanings, are reacted with an amine of the general formula h 2 nar 2. Where K ^ and Ar have the indicated values of s in an organic ^ solvent selected from methanol, ethanol and propan-2-ol, in the presence of sodium borohydride or sodium cyanoborohydride at a temperature from ambient temperature to the boiling point of the reaction mixture.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1209026A3|1986-01-30|Method of producing arylcyclobutylalkylamino compounds
    FI95128C|1995-12-27|A process for the preparation of new therapeutically useful diphenylpropylamine derivatives
    Do Minh et al.1977|Reactions of phthalaldehyde with ammonia and amines
    LU84070A1|1983-06-07|PHENYLCYCLOBUTYL DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
    CA1184180A|1985-03-19|1-|-2-, or -3- | ethanone or propanonederivatives; process for preparing them and theiruse as drugs
    FR2538388A1|1984-06-29|NOVEL NAPHTHALENE OR AZANAPHTALENECARBOXAMIDE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS
    EP0828484A1|1998-03-18|Use of aryl substituted cyclobutyl alkyl amines for the treatment of obesity
    FI62300C|1982-12-10|PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ANALYSIS 1-RYL-2- | -ETHYL SULFIDERATE
    CA2781858C|2015-03-31|Modulators of tnf-.alpha. signaling
    US5852019A|1998-12-22|Pyrimidinylpyrazole derivatives
    FR2548666A1|1985-01-11|New nortropane and granatane derivatives, process for their preparation and their application in therapeutics
    FI69835B|1985-12-31|FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBARA 3-NDOLYL-TERTIAERBUTYLAMINOPROPANOLDERIVAT
    CH655104A5|1986-03-27|TRIAZOLIC HETEROCYCLIC DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME.
    FR2671551A1|1992-07-17|NOVEL ARYL TRIAZINIC STRUCTURE COMPOUNDS, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
    SK3702001A3|2001-12-03|2-phenylpyran-4-one derivatives
    FR2645743A1|1990-10-19|THERAPEUTIC COMPOSITIONS BASED ON DI-SUBSTITUTED DERIVATIVES OF N, N | -DITRIMETHOXYBENZOYLE PIPERAZINES
    FR2650591A1|1991-02-08|NOVEL OXAZOLO PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
    EP0612716B1|1996-05-08|Process for the preparation of an optically pure aminoalcohol
    US4645778A|1987-02-24|2-|-3-isobutoxy-n-substituted-phenyl-n-benzyl-propylamines, their preparation and pharmaceutical use
    FR2624861A1|1989-06-23|TRICYCLIC CARBAMATES, PROCESS FOR PREPARING THEM AND THEIR THERAPEUTIC APPLICATION
    EP0322391B1|1992-03-25|New phenylalkylamine derivatives
    FR2516510A1|1983-05-20|SUBSTITUTED | -1-AMINOCARBONYLETHYL-4-PIPERAZINE DERIVATIVES USEFUL IN PHARMACY AND PROCESS FOR THEIR PREPARATION
    US3969363A|1976-07-13|Derivatives of 1-phenoxy-3-amino-propan-2-ol and process for their production
    US5473080A|1995-12-05|Substituted azabicycloheptane derivatives, their preparation and use
    CZ15995A3|1995-09-13|Indolinyl substituted derivatives of n-hydroxyurea and n-hydroxamic acid as well as pharmaceutical preparations based thereon
    同族专利:
    公开号 | 公开日
    AU1922483A|1984-04-12|
    AU557248B2|1986-12-11|
    FI77659C|1989-04-10|
    NO160511C|1989-04-26|
    IN159443B|1987-05-23|
    GB2127819A|1984-04-18|
    FI833454A|1984-03-31|
    EG16991A|1989-06-30|
    NZ205722A|1987-06-30|
    IL69735A|1988-11-15|
    DK435483D0|1983-09-23|
    NO833527L|1984-04-02|
    RO87341B|1985-08-31|
    PT77363A|1983-10-01|
    PT77363B|1986-03-20|
    GB8325779D0|1983-10-26|
    IE832109L|1984-03-30|
    PH21658A|1988-01-13|
    FI833454A0|1983-09-26|
    FI77659B|1988-12-30|
    BG40803A3|1987-02-16|
    PL243949A1|1984-07-16|
    DD212956A5|1984-08-29|
    PL139308B1|1987-01-31|
    GB2127819B|1986-05-21|
    US4629727A|1986-12-16|
    IE56000B1|1991-03-13|
    CS713083A2|1985-07-16|
    ZW19383A1|1984-05-02|
    NO160511B|1989-01-16|
    DE3362327D1|1986-04-03|
    EP0111994A1|1984-06-27|
    RO87341A|1985-08-31|
    ES8601850A1|1985-11-16|
    YU196583A|1986-04-30|
    CS241067B2|1986-03-13|
    ES526088A0|1985-11-16|
    HU193417B|1987-10-28|
    GR78991B|1984-10-02|
    EP0111994B1|1986-02-26|
    DK435483A|1984-03-31|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    RU2462451C2|2006-09-15|2012-09-27|Ривайва Фармасьютикалс, Инк.|Method of producing, methods of using and composition of cycloalkylmethylamines|
    RU2642074C2|2011-12-30|2018-01-24|Ревива Фармасьютикалс, Инк.|Compositions, synthesis and methods for application of phenylcycloalkylmethylamine derivatives|DE1124485B|1960-02-12|1962-03-01|Hoechst Ag|Process for the preparation of analeptically active phenylcycloalkylmethylamines|
    SE7600674L|1975-02-05|1976-08-06|Rohm & Haas|FUNGICIDER|
    ZA821577B|1981-04-06|1983-03-30|Boots Co Plc|Therapeutic agents|
    US4443449A|1981-04-06|1984-04-17|The Boots Company Limited|Arylcyclobutylalkylamines and anti-depression composition and methods using same|
    IE52768B1|1981-04-06|1988-02-17|Boots Co Ltd|1-arylcyclobutylalkylamine compounds useful as therapeutic agents|AU576307B2|1982-09-24|1988-08-25|Commonwealth Scientific And Industrial Research Organisation|Arthropodicidal compounds|
    GB8501192D0|1985-01-17|1985-02-20|Boots Co Plc|Therapeutic agents|
    IL79796A|1985-08-27|1991-06-30|Ciba Geigy Ag|3-carboxy piperidine and/or tetrahydropyridine derivatives,process for their preparation and pharmaceutical compositions comprising them|
    GB8531071D0|1985-12-17|1986-01-29|Boots Co Plc|Therapeutic compound|
    GB8704777D0|1987-02-28|1987-04-01|Boots Co Plc|Medical treatment|
    GB9309749D0|1993-05-12|1993-06-23|Boots Co Plc|Therapeutic agents|
    GB9915617D0|1999-07-05|1999-09-01|Knoll Ag|Therapeutic agents|
    WO2003078376A1|2002-03-13|2003-09-25|Schering Corporation|Nk1 antagonists|
    WO2012003501A2|2010-07-02|2012-01-05|Reviva Pharmaceuticals, Inc.|Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    GB8227898|1982-09-30|
    GB8227901|1982-09-30|
    [返回顶部]